Advanced clinical imaging for the evaluation of stem cell based therapies.
Michail E KlontzasGeorge A KakkosGeorgios Z PapadakisKonstantinos MariasApostolos H KarantanasPublished in: Expert opinion on biological therapy (2021)
Introduction: As stem cell treatments reach closer to the clinic, the need for appropriate noninvasive imaging for accurate disease diagnosis, treatment planning, follow-up, and early detection of complications, is constantly rising. Clinical radiology affords an extensive arsenal of advanced imaging techniques, to provide anatomical and functional information on the whole spectrum of stem cell treatments from diagnosis to follow-up.Areas covered: This manuscript aims at providing a critical review of major published studies on the utilization of advanced imaging for stem cell treatments. Uses of magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and positron emission tomography (PET) are reviewed and interrogated for their applicability to stem cell imaging.Expert opinion: A wide spectrum of imaging methods have been utilized for the evaluation of stem cell therapies. The majority of published techniques are not clinically applicable, using methods exclusively applicable to animals or technology irrelevant to current clinical practice. Harmonization of preclinical methods with clinical reality is necessary for the timely translation of stem cell therapies to the clinic. Methods such as diffusion weighted MRI, hybrid imaging, and contrast-enhanced ultrasound hold great promise and should be routinely incorporated in the evaluation of patients receiving stem cell treatments.
Keyphrases
- stem cells
- computed tomography
- magnetic resonance imaging
- high resolution
- positron emission tomography
- contrast enhanced
- diffusion weighted
- clinical practice
- magnetic resonance
- pet ct
- primary care
- fluorescence imaging
- bone marrow
- diffusion weighted imaging
- mesenchymal stem cells
- dual energy
- machine learning
- image quality
- case control